Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
123,092,608
-
Share change
-
+1,054,240
-
Total reported value
-
$34,213,653,795
-
Put/Call ratio
-
87%
-
Price per share
-
$278.03
-
Number of holders
-
970
-
Value change
-
+$294,517,003
-
Number of buys
-
395
-
Number of sells
-
443
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2023
As of 31 Mar 2023,
BIOGEN INC. - COM (BIIB) was held by
970 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
123,092,608 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Clearbridge Investments, LLC, and FMR LLC.
This page lists
986
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.